CATEGORIES: CMT Update

Taking Matters Into Your Own Hands

by | Mar 9, 2015 | 0 comments

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

1) Join the global registries for inherited neuropathies (GRIN).

2) Join the Inspire Community at: Charcot-Marie-Tooth (CMT) Support Community – Inspire.

3) Create a Facebook page specifically for CMT2D or your form of CMT and encourage all patients that find you to join the GRIN.

4) Go www.pubmed.com and do a search on CMT2D or your form of CMT and to learn where your form of CMT is being worked on. Reach out to the authors of research papers (an email address should be included at the bottom of the abstract).

5) Email every scientist in the world working on your form of CMT and ask if they need a skin biopsy from patients to advance research. Hopefully, your local university has success in growing out skin fibroblast cell lines following punch biopsies. They would grow out a large number of skin fibroblast cells that they would freeze into 10 separate vials. You could then have a vial shipped to 10 different labs studying your form of CMT. They would ship overnight, on dry ice. HNF can help with this process if cells are needed by researchers.

Initially, the most important thing is to find other patients with your form of CMT and ask if they too will have skin biopsies performed. If you are able to fundraise, you can earmark the funds for your type of CMT, through the Hereditary Neuropathy Foundation. We can help identify what the status of the field is for your form of CMT, and help prioritize research initiatives that need funding.

With over 80 different CMT causal genes now identified, patients must become active and helping to drive research. Except for CMT1A, CMT2A and CMTX, all other forms are considered ultra-rare, meaning less than 600 Americans are impacted.

Rare forms of CMT must unite in order to help fund, and drive research, to advance to the point where a pharmaceutical company may be interested in further investing in an ultra-rare CMT. Seed funding is needed for basic research until a discovery is made that peeks the interest of industry. TOGETHER, we will make a difference for ALL forms of CMT!

Learn more on this topic

Related Blog Posts

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

A Rare Disease Patient That Does It All!

A movie script could not play out like this. There are very few occasions when a rare disease patient becomes the topic of a story that is truly uplifting. Often the stories are tragic or disheartening. That was not the case, however, with CMT patient Kim Goodsell.

Hot Off the Press

One of the ways that some CMT patients first become aware of their disease is when they are given a drug treatment for another disease. This is termed chemotherapy-induced neurotoxicity. Drugs such as paclitaxel and the vinca alkaloids that are widely used in cancer treatment cause severe peripheral neuropathy and in some patients this exacerbates CMT, revealing it perhaps for the first time.

Kara Q&A: How to “support” a friend or family member that’s affected with Charcot-MarieTooth.

My name is Courtney Hollett, Fundraising Coordinator at the Hereditary Neuropathy Foundation. This time of year I count my blessing daily and wanted to share with you a Q&A session I had with a new supporter of HNF. Kara, like myself has many family members affected with CMT and I reached out to her to share her thoughts and advice about how to “support” a friend or family member that’s affected with Charcot-MarieTooth.

Collaboration is the Key to HNF Success

Collaboration is the Key to HNF Success

We at HNF are so proud of the accomplishments of those scientists we fund and are asking you to please continue to support our efforts. Our Therapeutic Research In Accelerated Discovery (TRIAD) program is a proven collaborative model in the drug discovery process.

Sneak Peak of Fall Newsletter: CMT Research Study Survey

My name is Elizabeth Francisco and I am a graduate student from the Genetic Counseling program at the University of North Carolina Greensboro. I am inviting you to participate in a research study. The goal of my study is to learn more about the experiences of people with Charcot-Marie-Tooth (CMT) with genetic counseling and genetic testing. Adults with CMT and parents or legal guardians of someone of any age who has a diagnosis of CMT are eligible to participate

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news